Published in
Springer Nature [academic journals on nature.com], British Journal of Cancer, 11(119), p. 1326-1331, 2018
DOI: 10.1038/s41416-018-0307-3
Links
Tools
Cytidine deaminase enzymatic activity is a prognostic biomarker in gemcitabine/platinum-treated advanced non-small-cell lung cancer: a prospective validation study.
Journal article published in 2018 by
Carmelo Tibaldi,
Andrea Camerini,
Marcello Tiseo,
Francesca Mazzoni,
Fausto Barbieri,
Isabella Vittimberga,
Matteo Brighenti,
Luca Boni,
Editta Baldini,
Annalisa Gilli,
Richard Honeywell 
,
Myriam Chartoire,
Peters Gj,
Godefridus J. Peters,
Italian Oncological Group of Clinical Research (Goirc)
and other authors.
,
Myriam Chartoire,
Peters Gj,
Godefridus J. Peters,
Italian Oncological Group of Clinical Research (Goirc)
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 